Home

Monash Antibody Discovery Platform (MADP) provides services for antibody discovery, antibody production, antibody sequencing and cell line cryopreservation.  The primary focus in the core is generating high-affinity monoclonal antibodies that are specific for the customer’s needs but we also offer a range of services related to cell line work and antibody characterisation.

Beacon Grant

Decode Science, in partnership with Bruker and the Monash Antibody Discovery Platform, is offering 3 grants across Australia and New Zealand access to Bruker's Beacon Optofluidic Technology.

Three grant categories are available:

  • Category 1, Monash Grant - 80% Off
  • Category 2, ANZ Open Grant - 80% Off
  • Category 3, ANZ Industry - 80% Off

All categories require a scientific abstract of 500–700 words covering your project rationale, objectives, sample type, and expected outcomes.

Shortlisted applicants who are unsuccessful will receive 25% off reagents and consumables for their next Beacon project so a strong application has value regardless of outcome.

If you have any queries, simply contact Hayley (hayley.ramshaw@monash.edu) or Julia (julia.young@decodescience.com.au) via email or submit your abstract using the link below.

Submit Your Abstract

About us

Monoclonal Antibody & Cell Line Services

Robocore

New Technologies

Monoclonal Antibody Characterisation

Working With Us

QUALITY: As part of the Monash Research Platform Network, we are committed to providing excellence and quality through all stages of research, industry engagement and collaborations. To achieve this objective, we have implemented a platform quality management system that complies with the requirements of ISO 9001:2015 Quality Management System.